Atropine Sulphate

Country: অস্ট্রেলিয়া

ভাষা: ইংরেজি

সূত্র: Department of Health (Therapeutic Goods Administration)

সক্রিয় উপাদান:

atropine sulfate monohydrate, Quantity: 600 microgram

থেকে পাওয়া:

Aspen Pharma Pty Ltd

INN (International Name):

atropine sulfate monohydrate

ফার্মাসিউটিকাল ফর্ম:

Tablet, uncoated

রচনা:

Excipient Ingredients: povidone; lactose monohydrate; maize starch; purified talc; magnesium stearate

প্রশাসন রুট:

Oral

প্যাকেজ ইউনিট:

100 Tablets, 100 Tablets (E)

শ্রেণী:

Medicine Registered

প্রেসক্রিপশন টাইপ:

(S4) Prescription Only Medicine, Not scheduled. Not considered by committee

থেরাপিউটিক ইঙ্গিত:

For the treatment of muscarinic toxicity resulting from exposure to anticholinesterase compounds (e.g. organophosphate pesticides). Atropine tablets are not as effective as I.V. Atropine, which is almost always required for significant organophosphate poisoning. However atropine tablets are of value when medical assistance is not readily available, and is indicated as a short term antidote pending access to professional medical treatment. Atropine tablets are not recommended for prophylaxis for pesticide poisoning. Atropine does not prevent pesticide poisoning; attempts to use atropine tablets for this purpose have lead to several cases of mild atropine poisoning as well as chronic organophosphate poisoning.

পণ্য সারাংশ:

Visual Identification: Plain white round biconvex tablet, uncoated radius of curvature 21/64" diameter 9/32"; Container Type: Bottle; Container Life Time: 2 Years

অনুমোদন অবস্থা:

Registered

অনুমোদন তারিখ:

1991-08-30

তথ্য লিফলেট

1
ATROPINE SULFATE TABLETS
_Atropine Sulfate_
_ _
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET?
This leaflet answers some
common questions about
ATROPINE SULFATE
tablets.
It does not contain all of
the available information.
It does not take the place
of talking to your doctor
or pharmacist.
All medicines have risks
and benefits. Your doctor
has weighed the risks of
you taking ATROPINE
SULFATE tablets against
the benefits he/she expect
it will have.
IF YOU HAVE ANY CONCERNS
ABOUT TAKING THIS
MEDICINE, ASK YOUR
DOCTOR OR PHARMACIST.
KEEP THIS LEAFLET WITH THE
MEDICINE.
You may need
to read it again.
WHAT IS ATROPINE
SULFATE?
The name of your
medicine is ATROPINE
SULFATE tablets.
The active ingredient is
called atropine sulfate.
_ _
_Atropine Sulfate _
belongs
to a group of medicines
called antimuscarinics.
These are drugs that
inhibit the adverse
muscarinic actions of
certain other drugs and
chemicals classed as
anticholinesterase agents.
For example, in
organophosphate
poisoning, the muscarinic
effects of poisoning
(excessive saliva,
sweating, vomiting,
diarrhoea and constricted
pupils) are reversed by
atropine.
WHAT ATROPINE
SULFATE IS USED FOR
ATROPINE SULFATE
tablets is used for the short
term treatment of
organophosphate pesticide
poisoning in situations
where professional
medical services are not
immediately available. It
is important that medical
advice be obtained as soon
as possible.
ATROPINE SULFATE
tablets do not prevent
pesticide poisoning, and
should not be taken before
poisoning has actually
occurred.
Your doctor, however,
may have prescribed
ATROPINE SULFATE
for another purpose.
Ask your doctor if you
have any questions about
why ATROPINE
SULFATE has been
prescribed for you.
If you have any concerns,
you should discuss this
with your doctor.
ATROPINE SULFATE
tablets is available with a
doctor’s prescription.
They are also available
under special
circumstances without a
doctor’s prescription.
BEFORE YOU TAKE
ATROPINE SULFATE
TABLETS
_ _
_WHEN YOU MUST NOT TAKE IT _
Do not take ATROPINE
S

তথ্য লিফলেট

PARLODEL
®
_bromocriptine mesylate_
CONSUMER MEDICINE INFORMATION
WHAT IS IN THIS LEAFLET
This leaflet answers some common
questions about Parlodel.
It does not contain all the available
information. It does not take the
place of talking to your doctor or
pharmacist.
The information in this leaflet was
last updated on the date listed on the
final page. More recent information
on the medicine may be available.
YOU SHOULD ENSURE THAT YOU SPEAK
TO YOUR PHARMACIST OR DOCTOR TO
OBTAIN THE MOST UP TO DATE
INFORMATION ON THE MEDICINE. YOU
CAN ALSO DOWNLOAD THE MOST UP TO
DATE LEAFLET FROM
WWW.NOVARTIS.COM.AU.
Those updates may contain important
information about the medicine and
its use of which you should be aware.
All medicines have risks and
benefits. Your doctor has weighed
the risks of you taking Parlodel
against the benefits they expect it
will provide.
IF YOU HAVE ANY CONCERNS ABOUT THIS
MEDICINE, ASK YOUR DOCTOR OR
PHARMACIST.
KEEP THIS LEAFLET WITH THE MEDICINE.
You may need to read it again.
WHAT PARLODEL IS USED
FOR
Parlodel has several uses. It can be
used for the following medical
conditions:
1.
Prevention/suppression of breast
milk production (lactation) in
women who cannot/do not breast-
feed for medical reasons. If breast
milk production has already
begun, your doctor can advise
you about other methods of
stopping lactation.
2.
Treatment of people who have
high blood levels of a hormone
called prolactin. This condition is
sometimes caused by a type of
tumour called a prolactinoma.
3.
Treatment of acromegaly, a
disease in which the body
produces too much growth
hormone. Parlodel treats this
disease by reducing the level of
growth hormone in the blood.
4.
To relieve symptoms, such as
shaking of the limbs, stiffness and
slowness of movement, in people
with Parkinson's disease. Parlodel
is often used in combination with
other medicines such as levodopa.
Parlodel contains the active
ingredient, bromocriptine. It belongs
to a group of medicines known as the
ergot alkaloids, derived from a type
of fungus.
ASK

পণ্য বৈশিষ্ট্য

1
AUSTRALIAN PRODUCT INFORMATION PARLODEL
®
(BROMOCRIPTINE MESILATE
)
TABLET AND HARD CAPSULE
1
NAME OF THE MEDICINE
Bromocriptine mesilate
2
QUALITATIVE AND QUANTITATIVE COMPOSITION
•
Parlodel tablets and capsules contain bromocriptine mesilate
•
Oral tablets:
➢
2.5 mg bromocriptine (present as 2.9 mg mesilate).
•
Oral capsules:
➢
10 mg bromocriptine (present as 11.5 mg mesilate).
➢
5 mg bromocriptine (present at 5.735 mg mesilate).
•
List of excipients with known effect: lactose and sugars.
•
For the full list of excipients, see Section 6.1 List of excipients.
3
PHARMACEUTICAL FORM
Oral tablets:
•
White, coded XC with breakline on one side, SANDOZ on the other side.
Oral capsules:
•
5 mg: opaque white and opaque blue, marked PS
•
10 mg: opaque white
4
CLINICAL PARTICULARS
4.1
T
HERAPEUTIC INDICATIONS
•
Prevention of onset of lactation in the puerperium for clearly defined
medical reasons.
Therapy should be continued for 14 days to prevent rebound lactation.
Parlodel should not
be used to suppress established lactation.
•
Treatment of hyperprolactinaemia where surgery and/or radiotherapy are
not indicated or
have already been used with incomplete resolution. Precautions should
be taken to ensure
that the hyperprolactinaemia is not due to severe primary
hypothyroidism. Where the cause
of hyperprolactinaemia is a prolactin-secreting microadenoma or
macroadenoma, Parlodel
is indicated for conservative treatment; prior to surgery in order to
reduce tumour size and
to facilitate removal; after surgery if prolactin level is still
elevated.
•
Adjunctive therapy in the management of acromegaly when:
(1)
The patient refuses surgery and/or radiotherapy
(2)
Surgery and/or radiotherapy has been unsuccessful or full effects are
not expected for
some months
(3) A manifestation of the acromegaly needs to be brought under
control pending surgery
and/or radiotherapy.
2
•
Idiopathic or post-encephalitic Parkinson's disease. It should be
noted that data are not yet
sufficient to evaluate the role of